Showing results (101-110 of 156) with videos related to
Sort By:
Pageof 16
Journal of Clinical Medicine|November 27, 2024
Acute Liver Failure Etiology Determines Long-Term Outcomes in Patients Undergoing Liver Transplantation: An Analysis of the UNOS DatabaseNatalia Rojas Amaris, Ana Marenco-Flores, Romelia Barba, et al.World Journal of Transplantation|December 8, 2025
Association of vascular invasion and tumor differentiation on post-liver transplant outcomes in patients with hepatocellular carcinomaNazlı Begüm Öztürk, Merve M Gurakar, Ximena Parraga, et al.Annals of Hepatology|November 22, 2021
Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant - A retrospective cohort analysisKillian J McCarthy, Daniel Motta-Calderon, Alisson Estrada-Roman, et al.Journal of Clinical Medicine|August 10, 2024
The External Validation of GLOBE and UK-PBC Risk Scores for Predicting Ursodeoxycholic Acid Treatment Response in a Large U.S. Cohort of Primary Biliary Cholangitis PatientsAna Marenco-Flores, Natalia Rojas Amaris, Tamara Kahan, et al.Hepatology (Baltimore, Md.)|October 24, 2009
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonrespondersVinod K Rustgi, William M Lee, Eric Lawitz, et al.European Journal of Gastroenterology & Hepatology|February 20, 2025
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinomaMarwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, et al.Annals of Hepatology|December 27, 2023
Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United StatesLeandro Sierra, Ana Marenco-Flores, Romelia Barba, et al.Journal of Clinical Medicine|October 28, 2023
Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver TransplantationsEsli Medina-Morales, Mohamed Ismail, Romelia Barba Bernal, et al.Hepatology (Baltimore, Md.)|May 13, 2015
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trialsSaleh A Alqahtani, Nezam Afdhal, Stefan Zeuzem, et al.Lancet (London, England)|December 14, 2012
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyPatrick Marcellin, Edward Gane, Maria Buti, et al.Pageof 16